MABYLON
LIVE

Serial Number

79227503

Owner

Mabylon AG

Filing Date

Nov 16, 2017

Add to watchlist:

No watchlists yet
View on USPTO

MABYLON Trademark

Serial Number: 79227503 • Registration: 5558008

MABYLON is a trademark filed by Mabylon AG on November 16, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Mabylon AG

Wagistrasse 14

Entity Type: 25

Trademark Details

Filing Date

November 16, 2017

Registration Date

September 11, 2018

Published for Opposition

June 26, 2018

Cancellation Date

March 28, 2025

Goods & Services

Medical and veterinary services; hygienic and beauty care for human beings or animals; services provided by consultants in the pharmaceutical field

Scientific services, namely, scientific research, analysis, testing, clinical trials, biological research and antibody design services particularly relating to immune and autoimmune diseases; preparation of technical reports for therapeutic antibody discovery and development purposes; research regarding medicines; technological services, namely, technological research and design in the field of therapeutic antibody discovery and development as well as research and new product design services relating thereto; industrial analysis and research services in the field of immune and inflammatory related diseases and disorders

Pharmaceutical and veterinary products for the treatment of autoimmune related diseases and disorders and inflammatory related diseases and disorders; medical preparations for the treatment of immune diseases, protein products, namely, human-derived monoclonal antibodies, antigens in the nature of cells for medical use; chemical preparations for medical use for the treatment of autoimmune related diseases and disorders and inflammatory related diseases and disorders as well as other acute or chronic conditions of unmet medical need; diagnostic substances, preparations and agents for medical use; diagnostic substances for medical use; medical preparations for the determination of biologically active substances, antiallergenic medical preparations and substances; medical and diagnostic preparations for enzyme determination

Medical apparatus and instruments, in particular for immune disease diagnosis or determination

Chemical products for use in industry and science; biochemical products, namely, antibodies for scientific or research use, other than for medical use

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 28, 2025 INTR
CANCELLED SECTION 71
Mar 28, 2025 C71T
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 5, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 19, 2018 FICS
FINAL DISPOSITION PROCESSED
Dec 19, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 11, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 11, 2018 R.PR
PUBLISHED FOR OPPOSITION
Jun 26, 2018 PUBO
NOTICE OF PUBLICATION
Jun 6, 2018 NPUB
EXAMINERS AMENDMENT MAILED
May 18, 2018 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
May 17, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
May 17, 2018 XAEC
EXAMINERS AMENDMENT -WRITTEN
May 17, 2018 CNEA
REFUSAL PROCESSED BY IB
Mar 31, 2018 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 15, 2018 RFCS
REFUSAL PROCESSED BY MPU
Mar 15, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 9, 2018 RFCR
NON-FINAL ACTION WRITTEN
Mar 8, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 6, 2018 MAFR
ASSIGNED TO EXAMINER
Feb 28, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 28, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 22, 2018 REPR